STOCK TITAN

Freshpet (NASDAQ: FRPT) CEO sells 44K shares, exercises 84K options

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) CEO William B. Cyr reported option exercises and related share sales. He exercised options for 84,000 shares of common stock at an exercise price of $10.23 per share (directly and through spouse-related trusts) and sold a net 44,078 shares, including 41,028 direct shares at a weighted average price around $74.80. The sales were effected under a Rule 10b5-1 trading plan adopted on November 5, 2025.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 44,078 shs ($3.29M)
Approx. gross sale proceeds $3.29M
Approx. exercise cost $859K
Type Security Shares Price Value
Exercise Options to purchase common stock F4 62,369 $0.00 $0.00
Exercise Options to purchase common stock F4 4,620 $0.00 $0.00
Exercise Options to purchase common stock F4 9,030 $0.00 $0.00
Exercise Options to purchase common stock F4 7,981 $0.00 $0.00
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock F1, F2, F3 41,028 $74.80 $3.07M
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock F1 652 $73.58 $48K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock F1 1,273 $73.58 $94K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock F1 1,125 $73.58 $83K
Holdings After Transaction: Options to purchase common stock — 181,179 shares (Direct); Options to purchase common stock — 13,420 shares (Indirect, By Spouse); Options to purchase common stock — 26,230 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Options to purchase common stock — 23,171 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants); Common Stock — 288,493 shares (Direct); Common Stock — 37,471 shares (Indirect, By Spouse); Common Stock — 83,907 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Common Stock — 76,692 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants)
Footnotes (4)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.804 to $74.806.
  3. F3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
  4. F4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Total shares sold 44,078 shares Net shares sold across direct and indirect transactions reported in this Form 4
Direct shares sold 41,028 shares Common stock sold directly by William B. Cyr at weighted average price around $74.80
Indirect shares sold 3,050 shares Common stock sold indirectly by spouse and related trusts at $73.58 per share
Options exercised 84,000 shares Total underlying shares from option exercises across direct and spouse-related entities
Option exercise price $10.23 per share Exercise price for options to purchase Freshpet common stock
Direct sale weighted average price range $74.804–$74.806 per share Price range for multiple direct sale transactions included in the weighted average
Indirect sale price $73.58 per share Per-share sale price for indirect sales by spouse and related trusts
Rule 10b5-1 plan adoption date November 5, 2025 Adoption date of the trading plan under which the sales were effected
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan."
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Irrevocable Trust financial
"By Irrevocable Spousal Trust for Linda W. Cyr"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What did FRPT CEO William B. Cyr report in this Form 4?

He reported exercising options for 84,000 shares of Freshpet common stock at $10.23 per share and selling a net 44,078 shares, including 41,028 direct shares at a weighted average price around $74.80, plus smaller indirect sales through spouse-related trusts.

How many Freshpet (FRPT) shares did the CEO sell in this filing?

The filing shows total reported sales of 44,078 shares of Freshpet common stock, consisting of 41,028 direct shares and 3,050 indirect shares sold through spouse and related trusts, at per-share prices around $74.80 and $73.58.

At what prices were the FRPT shares sold by William B. Cyr?

Direct sales of 41,028 shares were at a weighted average price around $74.80 per share, with individual trades between $74.804 and $74.806. Indirect sales of 3,050 shares by spouse-related entities were at $73.58 per share.

What option exercise price did the FRPT CEO pay for the shares?

The options exercised by William B. Cyr, directly and through spouse-related entities, had an exercise price of $10.23 per share for an aggregate of 84,000 shares of Freshpet common stock.

Were the FRPT insider sales under a Rule 10b5-1 plan?

Yes. The filing states that the sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by William B. Cyr on November 5, 2025.

What plan governed the options exercised by the FRPT CEO?

The options exercised, covering in total 84,000 shares of Freshpet common stock, were issued under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/19/2026M62,369A$10.23329,521D
Common Stock08/19/2026S(1)41,028D$74.8(2)(3)288,493D
Common Stock08/19/2026M4,620A$10.2338,123IBy Spouse
Common Stock08/19/2026S(1)652D$73.5837,471IBy Spouse
Common Stock08/19/2026M9,030A$10.2385,180IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/19/2026S(1)1,273D$73.5883,907IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/19/2026M7,981A$10.2377,817IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/19/2026S(1)1,125D$73.5876,692IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2308/19/2026M62,369 (4)09/06/2026Common Stock62,369$0181,179D
Options to purchase common stock$10.2308/19/2026M4,620 (4)09/06/2026Common Stock4,620$013,420IBy Spouse
Options to purchase common stock$10.2308/19/2026M9,030 (4)09/06/2026Common Stock9,030$026,230IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2308/19/2026M7,981 (4)09/06/2026Common Stock7,981$023,171IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.804 to $74.806.
3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person08/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)